[1]杨勋能.参苓白术散对脓毒症患者肠道功能的影响[J].医学信息,2019,32(16):146-148.[doi:10.3969/j.issn.1006-1959.2019.16.049]
　YANG Xun-neng.Effect of Shenling Baizhu Powder on Intestinal Function in Patients with Sepsis[J].Journal of Medical Information,2019,32(16):146-148.[doi:10.3969/j.issn.1006-1959.2019.16.049]
点击复制

参苓白术散对脓毒症患者肠道功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年16期
页码:
146-148
栏目:
中医中药
出版日期:
2019-08-15

文章信息/Info

Title:
Effect of Shenling Baizhu Powder on Intestinal Function in Patients with Sepsis
文章编号:
1006-1959（2019）16-0146-03
作者:
杨勋能
自贡市第三人民医院急诊科，四川 自贡 643020
Author(s):
YANG Xun-neng
Department of Emergency,the Third People's Hospital of Zigong City,Zigong 643020,Sichuan,China
关键词:
参苓白术散; 脓毒症; 肠道功能
Keywords:
Key words：Shenling Baizhu Powder; Sepsis; Intestinal function
分类号:
R278
DOI:
10.3969/j.issn.1006-1959.2019.16.049
文献标志码:
A
摘要:
目的 探讨参苓白术散对脓毒症患者肠道功能的影响。方法 选取2017年3月~2019年3月我院收治的脓毒症患者82例，随机分为观察组和对照组，各41例。对照组予以抗感染及器官功能支持治疗，观察组在对照组基础上加用参苓白术散治疗，比较两组治疗前后炎性因子指标（IL-6、TNF-α）、肠道通透性指标（DAO、D-LAC）、住ICU时间、急性生理与慢性健康状况评分（APACHEⅡ评分）及病死率。结果 治疗后，观察组血清TNF-α、IL-6、DAO、D-LAC水平低于对照组[（38.91±5.18）ng/L vs（51.34±6.05）ng/L]、[（216.60±16.30）ng/L vs（327.49±20.42）ng/L]、[（4.01±1.27）IU/L vs（6.37±1.46）IU/L]、[（8.49±2.37）mg/ml vs（12.61±3.53）mg/ml]，差异有统计学意义（P＜0.05）；观察组APACHEⅡ评分、病死率低于对照组，住ICU时间短于对照组，差异有统计学意义（P＜0.05）。结论 参苓白术散可减脓毒症患者炎性反应和肠黏膜损伤，改善病情，缩短住ICU时间，降低病死率。
Abstract:
Abstract：Objective To investigate the effect of Shenling Baizhu Powder on intestinal function in patients with sepsis. Methods 82 patients with sepsis admitted to our hospital from March 2017 to March 2019 were randomly divided into observation group and control group, with 41 cases in each group. The control group received anti-infective and organ function support treatment. The observation group was treated with Shenqi Baizhu Powder on the basis of the control group. The inflammatory factor index (IL-6, TNF-α) and intestinal permeability were compared before and after treatment. Indicators (DAO, D-LAC), ICU time, acute physiology and chronic health status score (APACHE Ⅱ score), and case fatality rate. Results After treatment, the levels of serum TNF-α, IL-6, DAO and D-LAC in the observation group were lower than those in the control group [(38.91±5.18) ng/L vs (51.34±6.05) ng/L], [(216.60±16.30) ng/L vs (327.49±20.42) ng/L], [(4.01±1.27) IU/L vs (6.37±1.46) IU/L], [(8.49±2.37) mg/ml vs (12.61±3.53) mg/ml], the difference was statistically significant (P<0.05); the APACHEII score and mortality rate of the observation group were lower than that of the control group, and the ICU time was shorter than the control group, the difference was statistically significant (P<0.05).Conclusion Shenling Baizhu Powder can reduce inflammatory reaction and intestinal mucosal injury in patients with sepsis, improve the condition, shorten the time of ICU and reduce the case fatality rate.

参考文献/References:

[1]王晓静,高勇,李宁,等.连续性血液滤过对脓毒症休克患者PCT清除的影响[J].河北医科大学学报,2015,36(10):1177-1179. [2]高洁,孔令博,刘斯,等.血必净注射液治疗脓毒症及多器官功能障碍综合征的前瞻性多中心临床研究[J].中华危重病急救医学,2015,27(6):465-470. [3]张俊亮,曾其毅.脓毒症与胃肠道功能损伤的关系及研究进展[J].实用医学杂志,2016,32(17):2925-2927. [4]赵艳.参苓白术散加减方联合匹维溴铵片治疗腹泻型肠易激综合征临床观察及其作用机制探讨[J].河北中医,2016,38(6):876-879,923. [5]中华医学会重症医学分会.中国严重脓毒症/脓毒性休克治疗指南(2014)[J].中华危重病急救医学,2015,27(6):401-403. [6]陈分乔,许文忠,高海运,等.中药肠胃舒对脓毒症胃肠功能障碍患者的抗炎效果及肠道机械屏障保护作用[J].中国中西医结合急救杂志,2016,23(5):458-460. [7]高洁,孔令博,刘斯,等.血必净注射液治疗脓毒症及多器官功能障碍综合征的前瞻性多中心临床研究[J].中华危重病急救医学,2015,27(6):465-470. [8]林瑾,王海曼,李昂.多器官功能障碍综合征患者胃肠功能损伤流行病学调查[J].中国临床医学杂志,2009,16(6):863-864. [9]夏国莲,江荣林,雷澍,等.基于床旁JY-DLT肠道屏障功能检测系统分析参苓白术散对脓毒症胃肠功能障碍患者肠黏膜屏障的影响[J].中华中医药杂志,2019,34(3):1293-1296. [10]肖莹莹,周仙仕,唐光华.脓毒症患者中医证候与预后的关系[J].中医杂志,2016,57(3):224-227. [11]王雪梅.参苓白术散对溃疡性结肠炎患者血浆MMP-2、MMP-9水平的影响[J].环球中医药,2016,9(4):398-401. [12]骆俊,徐春燕,赵凯.参苓白术散对脾虚气滞型功能性消化不良患儿血清胃肠激素和胃电图的影响[J].上海中医药杂志,2016,19(10):50-52. [13]黄玉珍,刘万里,诸葛远莉.参苓白术散对脾虚泄泻幼鼠肠粘膜屏障的修复作用[J].中医药学报,2016,44(5):40-43. [14]左阿芳,夏国莲.参苓白术散治疗老年脓毒症合并肠功能障碍患者的临床研究[J].中华全科医学,2019,17(2):219-233.

相似文献/References:

[1]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
　WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Journal of Medical Information,2018,31(16):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[2]申 贵,彭 翔,秦光梅.抗感染督导治疗对脓毒症患者预后影响的研究[J].医学信息,2019,32(01):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
　SHEN Gui,PENG Xiang,QIN Guang-mei.Study on the Effect of Anti-infective Supervision on the Prognosis of Patients with Sepsis[J].Journal of Medical Information,2019,32(16):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
[3]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
　ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Journal of Medical Information,2019,32(16):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
[4]张文旭,徐 绸.红细胞宽度对脓毒症患者病情诊断及预后评估的价值[J].医学信息,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
　ZHANG Wen-xu,XU Chou.The Value of Red-blood-cell Distribution Width in the Diagnosis and Prognosis of Patients with Sepsis[J].Journal of Medical Information,2022,35(16):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
[5]朱思哲,叶成林.基于生物信息学分析构建免疫相关基因脓毒症预后模型[J].医学信息,2022,35(15):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
　ZHU Si-zhe,YE Cheng-lin.Identification of Immune-related Gene Prognostic Model for Sepsis Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(16):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
[6]杜金洁,胡 鹏.ESKAPE病原菌感染引起脓毒症的研究[J].医学信息,2019,32(21):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
　DU Jin-jie,HU Peng.Study on Sepsis Caused by ESKAPE Pathogen Infection[J].Journal of Medical Information,2019,32(16):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
[7]刘安平,段海真,汪 松.抗菌肽LL-37的生物学活性及其作用[J].医学信息,2019,32(24):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
　LIU An-ping,DUAN Hai-zhen,WANG Song.Biological Activity and Effect of Antibacterial Peptide LL-37[J].Journal of Medical Information,2019,32(16):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
[8]陈冀远.右美托咪啶对脓毒症急性肾损伤患者肾功能及血管紧张素Ⅱ表达的影响[J].医学信息,2020,33(01):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
　CHEN Ji-yuan.Effect of Dexmedetomidine on Renal Function and Angiotensin Ⅱ Expression in Patients with Acute Renal Injury in Sepsis[J].Journal of Medical Information,2020,33(16):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
[9]赵振宇.miR-33表达与炎症反应的关系[J].医学信息,2020,33(02):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
　ZHAO Zhen-yu.Relationship Between miR-33 Expression and Inflammatory Response[J].Journal of Medical Information,2020,33(16):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
[10]石玉英,段训新,黄 龙.老年社区获得性肺炎并脓毒症患者sCD14和CD14+/HLA-DR表达及意义[J].医学信息,2020,33(02):86.[doi:10.3969/j.issn.1006-1959.2020.02.023]
　SHI Yu-ying,DUAN Xun-xin,HUANG Long.Expression and Significance of sCD14 and CD14+/HLA-DR in Elderly Patients with Community Acquired Pneumonia and Sepsis[J].Journal of Medical Information,2020,33(16):86.[doi:10.3969/j.issn.1006-1959.2020.02.023]

更新日期/Last Update: 2019-08-15